13 July 2015
For patients with severe haemophilia A, studies provide both hints and an indication of an added benefit of prophylactic versus on-demand treatment with factor concentrates.img src=”http://feeds.feedburner.com/~r/sciencedaily/~4/0JZ9US-Xsgs” height=”1″ width=”1″ alt=””/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/0JZ9US-Xsgs/150713113343.htm
